Endocrine Adjuvant Therapy for Localized Breast Cancer

Overview of attention for article published in New England Journal of Medicine, June 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 7 news outlets
twitter: 56 X users

facebook: 3 Facebook pages

Readers on

mendeley: 67 Mendeley

So far, Altmetric has seen 3 public wall posts from 3 users.

Integrative Oncology-Essentials Fan Page, 06 Jun 2018

Ovarian suppression plus Tamoxifen or an aromatase inhibitor improves survival over Tamoxifen or an aromatase inhibitor alone…

Dr Jane O'Brien-Specialist Oncoplastic Breast Cancer Surgeon, 05 Jun 2018

Aromatase inhibitor plus ovarian suppression yields benefit in high-risk premenopausal breast cancer patients according to new…

The New England Journal of Medicine, 04 Jun 2018

At 8 years of follow-up, premenopausal women with breast cancer had higher rates of disease-free and overall survival with the…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.